Expanded access
Showing 1 - 25 of 8,833
Acute Lymphoblastic Leukemia, With Appropriate Mutations, Acute Myeloid Leukemia, With NPM1 Mutations Trial (ziftomenib)
Available
- Acute Lymphoblastic Leukemia, With Appropriate Mutations
- Acute Myeloid Leukemia, With NPM1 Mutations
- (no location specified)
Feb 10, 2023
Relapsed/Refractory Higher-Risk Myelodysplastic Syndrome, Relapsed/Refractory Acute Myeloid Leukemia Trial (Magrolimab)
Available
- Relapsed/Refractory Higher-Risk Myelodysplastic Syndrome
- Relapsed/Refractory Acute Myeloid Leukemia
- Magrolimab
- (no location specified)
Jan 18, 2023
Metastatic Castration-Resistant Prostate Cancer Trial (Talazoparib)
Available
- Metastatic Castration-Resistant Prostate Cancer
- (no location specified)
Dec 6, 2022
Graft-versus-host Disease (GVHD) Trial (Ruxolitinib)
Approved for marketing
- Graft-versus-host Disease (GVHD)
- (no location specified)
Jan 26, 2023
Hypoparathyroidism Trial (Palopegteriparatide (TransCon PTH))
Available
- Hypoparathyroidism
- Palopegteriparatide (TransCon PTH)
- (no location specified)
Jan 10, 2023
Thrombotic Thrombocytopenic Purpura (TTP) Trial (TAK-755)
No longer available
- Thrombotic Thrombocytopenic Purpura (TTP)
- (no location specified)
Mar 3, 2023
Dravet Syndrome Trial (Fenfluramine Hydrochloride)
Approved for marketing
- Dravet Syndrome
- Fenfluramine Hydrochloride
- (no location specified)
Nov 8, 2022
Parkinson Disease Trial (HB- adMSCs (Hope Biosciences adipose derived mesenchymal stem cells))
Available
- Parkinson Disease
- HB- adMSCs (Hope Biosciences adipose derived mesenchymal stem cells)
- (no location specified)
Sep 20, 2023
Recurrent Glioblastoma Trial in Portland (TVI-Brain 1)
Available
- Recurrent Glioblastoma
- TVI-Brain 1
-
Portland, OregonProvidence St. Vincent Medical Center
Jun 28, 2023
Clear Cell Renal Cell Carcinoma Trial in Los Angeles (89Zr-DFO-girentuximab)
Available
- Clear Cell Renal Cell Carcinoma
- 89Zr-DFO-girentuximab
-
Los Angeles, CaliforniaUCLA
Oct 12, 2023